Find everything for your oncology department here.
 

Oncology: Oncology

DUBLIN, Ohio----Neoprobe Corporation , a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that it introduced a new gamma detection probe at the American College of Surgeons 92nd Annual Clinical Congress meeting in Chicago.
SAN FRANCISCO----AMERICAN SHARED HOSPITAL SERVICES , a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has finalized terms of its previously announced agreement to provide an image-guided radiation therapy system, a CT Simulator, and related service, support and maintenance services as part of a complete
For any company operating at the forefront of science, one of the best ways to generate publicity is to get positive results of its products published in leading academic journals.
Actelion Ltd announced today that the detailed analysis of the dose-finding study CONSCIOUS-1 has been presented at the Congress of Neurological Surgeons in Chicago by R. Loch Macdonald, MD, PhD, Professor of Surgery and Radiation & Cellular Oncology at University of Chicago Hospitals.
Dr. Edward James Kruse, who recently completed a surgical oncology fellowship at Virginia Commonwealth University in Richmond, has joined the Medical College of Georgia Section of Surgical Oncology as an assistant professor of surgery.
RESEARCH TRIANGLE PARK, N.C.----Cancer e search Incorporated, an oncology market research consulting firm, conducted a study to measure the increase in the price of cancer drug therapy in the United States.
STOCKHOLM, Sweden----ASTRO, the American Society for Therapeutic Radiology and Oncology will be holding its annual meeting this year at the Pennsylvania Convention Center in Philadelphia, Pennsylvania on November 5-9.
In the July 1, 2006 issue of the Journal of Clinical Oncology, Dr. Eggener and associates at Memorial Sloan Kettering Cancer Center describe a model that stratifies patients with a recurrence of renal cell carcinoma (RCCA) by risk factors to predict survival time. The authors applied the criteria previously described by Dr. Robert Motzer for patients with metastatic RCCA. [click link for full
In the epub edition of Radiotherapy and Oncology, Dr. Ishikawa and colleagues from the National Institute of Radiological Sciences, Chiba, Japan report on carbon ion (C-ion) beam radiotherapy for prostate cancer (CaP). With short-term follow-up they found it safe, potentially effective and with low toxicity. [click link for full article]
Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that the Journal of Clinical Oncology has published the final results of the PINNACLE trial, one of the largest multi-center studies ever done in the setting of relapsed mantle cell lymphoma (MCL). [click link for full article]

Add your Comment